Back to Search Start Over

Implementing hexaminolevulinate HCl blue light cystoscopy: a nursing perspective.

Authors :
Calvaresi AE
Trabulsi EJ
Sonzogni M
Gomella LG
Lallas CD
Wachsmuth KS
Source :
AORN journal [AORN J] 2014 Nov; Vol. 100 (5), pp. 489-96; quiz 497-9. Date of Electronic Publication: 2014 Oct 25.
Publication Year :
2014

Abstract

Hexaminolevulinate HCl is a diagnostic imaging agent used with blue light during cystoscopy to help detect non-muscle-invasive bladder cancer. Blue light cystoscopy performed using hexaminolevulinate HCl has been found to detect more papillary non-muscle-invasive bladder tumors than cystoscopy performed using standard white light. Because bladder instillation and retention requirements of hexaminolevulinate during cystoscopy can affect patient flow in the perioperative setting, this technique necessitates changes in nursing practice and care of patients with known or suspected non-muscle-invasive bladder cancer. Nursing personnel at one facility followed the AORN guidelines for preoperative patient care in the ambulatory setting to address staffing, preoperative nursing assessment, anesthesia evaluation, and preoperative teaching related to implementing blue light cystoscopy.<br /> (Copyright © 2014 AORN, Inc. Published by Elsevier Inc. All rights reserved.)

Details

Language :
English
ISSN :
1878-0369
Volume :
100
Issue :
5
Database :
MEDLINE
Journal :
AORN journal
Publication Type :
Academic Journal
Accession number :
25443119
Full Text :
https://doi.org/10.1016/j.aorn.2013.12.013